Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Invested Capital (2016 - 2025)

Historic Invested Capital for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to $528.1 million.

  • Usana Health Sciences' Invested Capital fell 94.04% to $528.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $528.1 million, marking a year-over-year decrease of 94.04%. This contributed to the annual value of $555.1 million for FY2024, which is 1147.04% up from last year.
  • According to the latest figures from Q3 2025, Usana Health Sciences' Invested Capital is $528.1 million, which was down 94.04% from $531.1 million recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Invested Capital registered a high of $555.1 million during Q4 2024, and its lowest value of $395.1 million during Q1 2022.
  • Its 5-year average for Invested Capital is $465.6 million, with a median of $462.1 million in 2023.
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 2681.58% in 2021, then crashed by 1053.46% in 2022.
  • Over the past 5 years, Usana Health Sciences' Invested Capital (Quarter) stood at $399.1 million in 2021, then grew by 8.87% to $434.5 million in 2022, then grew by 14.62% to $498.0 million in 2023, then grew by 11.47% to $555.1 million in 2024, then dropped by 4.87% to $528.1 million in 2025.
  • Its last three reported values are $528.1 million in Q3 2025, $531.1 million for Q2 2025, and $552.8 million during Q1 2025.